Timber Hill’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-9,600
Closed -$206K 863
2017
Q2
$206K Sell
9,600
-40,200
-81% -$811K 0.01% 853
2017
Q1
$854K Buy
49,800
+28,200
+131% +$491K 0.01% 1166
2016
Q4
$387K Sell
21,600
-103,000
-83% -$1.87M ﹤0.01% 1763
2016
Q3
$2.59M Sell
124,600
-232,400
-65% -$5.76M 0.01% 701
2016
Q2
$9.6M Buy
357,000
+230,200
+182% +$6.31M 0.05% 328
2016
Q1
$3.44M Buy
126,800
+114,200
+906% +$3.06M 0.02% 665
2015
Q4
$366K Sell
12,600
-158,200
-93% -$4.38M ﹤0.01% 1844
2015
Q3
$4.63M Buy
170,800
+146,600
+606% +$4.15M 0.02% 591
2015
Q2
$663K Sell
24,200
-63,400
-72% -$1.78M ﹤0.01% 1753
2015
Q1
$2.34M Buy
+87,600
New +$2.02M 0.01% 951
2014
Q4
Sell
-16,800
Closed -$400K 2663
2014
Q3
$400K Sell
16,800
-8,600
-34% -$198K ﹤0.01% 2117
2014
Q2
$587K Sell
25,400
-37,000
-59% -$817K ﹤0.01% 1997
2014
Q1
$1.42M Sell
62,400
-127,600
-67% -$2.72M 0.01% 1385
2013
Q4
$3.51M Sell
190,000
-101,000
-35% -$1.76M 0.01% 988
2013
Q3
$4.92M Buy
291,000
+4,000
+1% +$67.3K 0.02% 857
2013
Q2
$4.45M Buy
+287,000
New +$4.78M 0.02% 888

Other funds holding NVO

Timber Hill's NVO Position: Q4 2016 in Review

Timber Hill sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 23,116 shares — an estimated $419K sold.

Timber Hill first reported a position in NVO in Q2 2013 and held it in 7 quarters. The position peaked at $3.42M in Q3 2013. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • Timber Hill reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • Timber Hill sold 23,116 Novo Nordisk shares in Q4 2016, an estimated $419K.
  • Timber Hill first reported a position in Novo Nordisk in Q2 2013 and held it in 7 quarters.
  • Timber Hill's Novo Nordisk position peaked at $3.42M in Q3 2013.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Timber Hill's 13F filing for Q4 2016, filed 8 Feb 2017.